Stefania Fagagnini

Zurich, ZH, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

MRI and PET-CT Failed to Differentiate Between Hepatic Malignancy and Brucelloma.

MRI and PET-CT Failed to Differentiate Between Hepatic Malignancy and Brucelloma.

Journal: Open forum infectious diseases
Published: April 13, 2018

The Relevance of Vitamin and Iron Deficiency in Patients with Inflammatory Bowel Diseases in Patients of the Swiss IBD Cohort.

The Relevance of Vitamin and Iron Deficiency in Patients with Inflammatory Bowel Diseases in Patients of the Swiss IBD Cohort.

Journal: Inflammatory bowel diseases
Published: October 26, 2017

Severity of local inflammation does not impact development of fibrosis in mouse models of intestinal fibrosis.

Severity of local inflammation does not impact development of fibrosis in mouse models of intestinal fibrosis.

Journal: Scientific reports
Published: October 24, 2017

Myeloid differentiation primary response gene (MyD) 88 signalling is not essential for intestinal fibrosis development.

Myeloid differentiation primary response gene (MyD) 88 signalling is not essential for intestinal fibrosis development.

Journal: Scientific reports
Published: August 31, 2017

Risk factors for gallstones and kidney stones in a cohort of patients with inflammatory bowel diseases.

Risk factors for gallstones and kidney stones in a cohort of patients with inflammatory bowel diseases.

Journal: PloS one
Published: June 01, 2017

Anti-MMP-9 Antibody: A Promising Therapeutic Strategy for Treatment of Inflammatory Bowel Disease Complications with Fibrosis.

Anti-MMP-9 Antibody: A Promising Therapeutic Strategy for Treatment of Inflammatory Bowel Disease Complications with Fibrosis.

Journal: Inflammatory bowel diseases
Published: August 20, 2016

Decreased Fibrogenesis After Treatment with Pirfenidone in a Newly Developed Mouse Model of Intestinal Fibrosis.

Decreased Fibrogenesis After Treatment with Pirfenidone in a Newly Developed Mouse Model of Intestinal Fibrosis.

Journal: Inflammatory bowel diseases
Published: February 06, 2016

Single-dose pharmacokinetics and tolerability of oral delta-9- tetrahydrocannabinol in patients with amyotrophic lateral sclerosis.

Single-dose pharmacokinetics and tolerability of oral delta-9- tetrahydrocannabinol in patients with amyotrophic lateral sclerosis.

Journal: Drug metabolism letters
Published: February 25, 2012
Showing 1-8 of 8

Last Updated: 09/26/2026